This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

AAV-U7 Program


Drug Names(s): rAAV8

Description: Genethon's program is based on using an AAV8 (adeno-associated virus, serotype 8) vector carrying a transgene (U7) that allows the cellular machinery to skip over an exon 53 and produce ‘quasi-dystrophin’ in the patient’s muscle.

AAV-U7 Program News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug